A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM
Original Article from The New England Journal of Medicine — A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
Original Article from The New England Journal of Medicine — A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
In his State of the Union address, President Biden doubled down on his commitment to decreasing drug prices by expanding the number of drugs subject…
Find out about events that bring together rheumatology clinicians and professionals and their patients to directly discuss issues with stakeholders is an integral part of…
Deborah Dyett Desir, MD is the 87th ACR president and the first Black person elected to the position. In conversation with The Rheumatologist, this profile…
Weight-loss medications like semaglutide save on costs down the road. But is it enough?
Join the Biologics Prescribers Collaborative for the annual National Policy & Advocacy Summit on Biologics.
What concept represents the most important and transformational article ever written in all of rheumatology?As it turns out, coming to a consensus on the answer…
A review of prescription drug formularies last year revealed that a $10,000 brand drug for prostate cancer was preferred on a formulary, while its $450
Illustrated Glossary from The New England Journal of Medicine
Illustrated Glossary from The New England Journal of Medicine
Illustrated Glossary from The New England Journal of Medicine